Australien - engelsk - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - paracetamol, quantity: 500 mg; diphenhydramine hydrochloride, quantity: 25 mg - tablet, film coated - excipient ingredients: stearic acid; croscarmellose sodium; purified talc; potassium sorbate; povidone; maize starch; titanium dioxide; hypromellose; macrogol 3350; indigo carmine aluminium lake - for the temporary relief of pain when associated with sleeping difficulty, for example: headache, migraine, backache, arthritis, rheumatic and muscle pain, neuralgia, toothache or period pain. relief of fever.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - dextromethorphan hydrobromide monohydrate, quantity: 10.5 mg - pastille - excipient ingredients: menthol; acacia; saccharin sodium; white beeswax; betadex; quinoline yellow; sodium cyclamate; light liquid paraffin; maltitol solution; citric acid; flavour - bisolvon dry pastilles are used for the symptomatic treatment of dry, irritant, unproductive coughs and helps soothe the throat.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - dextromethorphan hydrobromide monohydrate, quantity: 2 mg/ml - oral liquid - excipient ingredients: propylene glycol; purified water; maltitol solution; methyl hydroxybenzoate; saccharin sodium; flavour; fragrance (perfume) - cough suppressant

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - paracetamol, quantity: 500 mg; ibuprofen, quantity: 200 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; croscarmellose sodium; microcrystalline cellulose; magnesium stearate; purified talc; maize starch; sodium lauryl sulfate; titanium dioxide; polyvinyl alcohol; glyceryl mono and dicaprylocaprate; macrogol poly(vinyl alcohol) grafted polymer; polysorbate 80; macrogol 3350; mica - temporary relief of acute pain and/or inflammation associated with headache, ,migraine headache, tension headache, sinus pain, toothache, dental procedures, backache, muscular aches and pains, period pain, sore throat, tennis elbow, rheumatic pain and arthritis and the aches and pains associated with colds and flu.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - hyoscine butylbromide -

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - hyoscine butylbromide, quantity: 20 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; povidone; lactose monohydrate; magnesium stearate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350; lecithin - spasm of the gastrointestinal tract.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - hyoscine butylbromide -

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - bromhexine hydrochloride -

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - bromhexine hydrochloride -

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - ipratropium bromide, quantity: 0.6 mg/ml - spray, solution - excipient ingredients: sodium hydroxide; sodium chloride; hydrochloric acid; disodium edetate; purified water; benzalkonium chloride - for the symptomatic relief of rhinorrhoea associated with allergic and non-allergic perennial rhinitis, and the common cold.